BARTOLINI, Alice
 Distribuzione geografica
Continente #
NA - Nord America 2.104
EU - Europa 1.140
AS - Asia 866
SA - Sud America 17
OC - Oceania 14
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.145
Nazione #
US - Stati Uniti d'America 2.080
CN - Cina 424
IT - Italia 422
SG - Singapore 197
DE - Germania 125
IE - Irlanda 87
GB - Regno Unito 69
SE - Svezia 60
UA - Ucraina 58
FI - Finlandia 54
JP - Giappone 48
FR - Francia 44
PL - Polonia 44
KR - Corea 37
VN - Vietnam 37
IN - India 30
ID - Indonesia 28
ES - Italia 27
AT - Austria 26
BE - Belgio 22
NL - Olanda 21
HK - Hong Kong 20
CH - Svizzera 18
GR - Grecia 18
TW - Taiwan 15
CA - Canada 14
AU - Australia 13
TR - Turchia 13
DK - Danimarca 11
BR - Brasile 9
NO - Norvegia 9
MX - Messico 8
HU - Ungheria 5
PT - Portogallo 5
RO - Romania 5
RU - Federazione Russa 5
AR - Argentina 3
MY - Malesia 3
PE - Perù 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
EG - Egitto 2
IR - Iran 2
UZ - Uzbekistan 2
BG - Bulgaria 1
CO - Colombia 1
EC - Ecuador 1
EU - Europa 1
HR - Croazia 1
JM - Giamaica 1
JO - Giordania 1
KW - Kuwait 1
LU - Lussemburgo 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
NZ - Nuova Zelanda 1
OM - Oman 1
PK - Pakistan 1
PR - Porto Rico 1
RS - Serbia 1
TH - Thailandia 1
TN - Tunisia 1
Totale 4.145
Città #
Chandler 205
Singapore 171
Fairfield 152
Santa Clara 139
Beijing 137
Ann Arbor 136
Ashburn 120
Woodbridge 104
Dublin 84
Torino 80
Houston 79
Seattle 78
Wilmington 74
Cambridge 57
Shanghai 57
Pisa 49
Milan 42
Warsaw 42
Dearborn 39
Turin 36
Columbus 34
Jacksonville 34
Nyköping 32
Jakarta 28
Redwood City 26
Vienna 26
Dong Ket 22
Medford 22
San Diego 22
Nanjing 21
Guangzhou 20
Princeton 20
Fremont 19
Helsinki 19
Villeurbanne 18
Shenyang 15
Dresden 14
Boardman 13
Brussels 13
Hangzhou 12
Pune 12
New York 11
Berlin 10
Boston 10
Paris 10
Tokyo 10
Wuhan 10
Bari 8
Hong Kong 8
Lappeenranta 8
Los Angeles 8
Phoenix 8
Redmond 8
Rome 8
Genoa 7
Madrid 7
Norwalk 7
Xian 7
Birmingham 6
Genova 6
London 6
Oxford 6
Rochester 6
San Jose 6
Seoul 6
Sydney 6
Taipei 6
Tübingen 6
Buffalo 5
Daejeon 5
Dallas 5
Düsseldorf 5
Freiburg im Breisgau 5
Istanbul 5
Nanchang 5
Padova 5
Toronto 5
Tower Hamlets 5
Upper Marlboro 5
Washington 5
Budapest 4
Burgwald 4
Central District 4
Chengdu 4
Falls Church 4
Frankfurt am Main 4
Gifu 4
Grafing 4
Mumbai 4
Ningbo 4
Oslo 4
Philadelphia 4
Renton 4
Tianjin 4
Utrecht 4
Woodsboro 4
Ancona 3
Bremen 3
Castiglion Fiorentino 3
Chicago 3
Totale 2.664
Nome #
Tracking a CAD-ALK gene rearrangement in urine and blood of a colorectal cancer patient treated with an ALK inhibitor 703
Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group 350
BCAM and LAMA5 Mediate the Recognition between Tumor Cells and the Endothelium in the Metastatic Spreading of KRAS Mutant Colorectal Cancer 335
Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer 301
Neuroblastoma-targeted nanocarriers improve drug delivery and penetration, delay tumor growth and abrogate metastatic diffusion 253
Molecular landscape of acquired resistance to targeted therapy combinations in BRAF mutant colorectal cancer 210
The neuronal pentraxin-2 pathway is an unrecognized target in human neuroblastoma which also offers prognostic value in patients 186
G-CSF administration to adult mice stimulates the proliferation of microglia but does not modify the outcome of ischemic injury. 179
Modulation of cell-cycle dynamics is required to regulate the number of cerebellar GABAergic interneurons and their rhythm of maturation 155
Radiologic and Genomic Evolution of Individual Metastases during HER2 Blockade in Colorectal Cancer 153
Development of cerebellar GABAergic interneurons: origin and shaping of the “minibrain” local connections 145
Abstract 5620: Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings 128
Abstract 3625: Novel phage-display derived peptides for tumor- and vasculature-targeted therapies in neuroblastoma 120
Abstract 1163: Microenvironment targets in KRAS-mutated metastatic colorectal cancer 118
Abstract 1778: Characterization and anti-tumor functionality of a neuroblastoma-specific peptide, either free or conjugated to nanocarriers 106
The prospective white matter: an atypical neurogenic niche in the developing cerebellum 101
Neurogenesis in the cerebellum of rodents 91
Temozolomide drives mismatch repair deficiency and fosters neoantigen generation in tumor cells 75
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial 71
Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance 68
Laminar fate and phenotype specification of cerebellar GABAergic interneurons 66
GCSF-mobilized hematopoietic stem cells in CMS ischemic lesion 61
Coexisting cancer stem cells with heterogeneous gene amplifications, transcriptional profiles, and malignancy are isolated from single glioblastomas 50
Abstract A120: Adaptive mutability of colorectal cancers in response to targeted therapies 22
Prediction of homologous recombination deficiency identifies colorectal tumors sensitive to PARP inhibition 21
DNA demethylation triggers cell free DNA release in colorectal cancer cells 20
Abstract 6262: Emergence of tumor mismatch repair deficiency and increased mutational burden in blood and tissue of metastatic colorectal cancer patients treated with temozolomide 19
Abstract 6402: The effects of cytotoxic chemotherapy on colorectal cancer immunogenicity 17
Mutational signatures of colorectal cancers according to distinct computational workflows 17
Abstract A001: Reshaping the immune microenvironment after temozolomide priming in metastatic colorectal cancer patients in ARETHUSA clinical trial 15
Post-surgery sequelae unrelated to disease progression and chemotherapy revealed in follow-up of patients with stage III colon cancer 15
Abstract B11: Whole-exome sequencing analysis of urine transrenal tumor DNA in metastatic colorectal cancer patients 15
Abstract 2913: Emergence of RAS or EGFR mutant clones affects duration of response to EGFR blockade in colorectal cancers 14
Abstract 2848: Radiographic and genomic evolution of individual metastases during HER2 blockade in colorectal cancer 14
Abstract 5723: Inactivation of DNA repair triggers neoantigen generation and impairs tumor growth 12
Abstract 3834: Tracking CAD-ALK gene translocation in urine and plasma of a colorectal cancer patient treated with ALK blockade 11
Abstract 2743: Accumulation of predicted neoantigens by MMR deficiency triggered by temozolomide treatment of human colorectal cancer 11
Single-Nuclei Transcriptome Profiling Reveals Intra-Tumoral Heterogeneity and Characterizes Tumor Microenvironment Architecture in a Murine Melanoma Model 9
Totale 4.257
Categoria #
all - tutte 10.916
article - articoli 0
book - libri 0
conference - conferenze 2.600
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.516


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020345 0 0 0 0 0 64 55 45 60 59 33 29
2020/2021409 22 29 17 32 26 32 42 26 40 57 29 57
2021/2022466 40 48 33 53 19 10 25 15 23 56 98 46
2022/2023607 45 67 16 57 59 95 40 59 73 16 43 37
2023/2024494 42 48 29 45 57 78 35 30 11 31 40 48
2024/2025654 19 68 134 134 217 82 0 0 0 0 0 0
Totale 4.257